The letter aims to discuss the pivotal findings of the recent study on oncolytic reovirus(RC402)focusing on its administration route and how this route enhances immunotherapeutic efficacy against advanced cancers.The ...The letter aims to discuss the pivotal findings of the recent study on oncolytic reovirus(RC402)focusing on its administration route and how this route enhances immunotherapeutic efficacy against advanced cancers.The insights gained from this study regarding oral reovirus treatment improve our understanding of oncolytic virotherapy and propose a feasible strategy for enhancing the efficacy of cancer immunotherapy.The research demonstrates that oral administration of RC402 can effectively induce antitumor immunity without significant toxicities.展开更多
文摘The letter aims to discuss the pivotal findings of the recent study on oncolytic reovirus(RC402)focusing on its administration route and how this route enhances immunotherapeutic efficacy against advanced cancers.The insights gained from this study regarding oral reovirus treatment improve our understanding of oncolytic virotherapy and propose a feasible strategy for enhancing the efficacy of cancer immunotherapy.The research demonstrates that oral administration of RC402 can effectively induce antitumor immunity without significant toxicities.
